XML 83 R74.htm IDEA: XBRL DOCUMENT v3.23.2
FAIR VALUE OF FINANCIAL INSTRUMENTS - Schedule of Fair Value Measurements of Cash and Cash Equivalents, Restricted Cash, Investments, Derivatives, and Unfunded Revolving and Delayed Draw Loan Commitments (Details) - USD ($)
$ in Millions
Jun. 30, 2023
Dec. 31, 2022
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]    
Cash and cash equivalents $ 411.0 $ 303.0
Restricted cash 42.0 34.0
Total investments 21,496.5 21,779.8
Derivatives (2.0) (21.0)
Unfunded revolving and delayed draw loan commitments (41.0) (57.0)
Total    
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]    
Total investments 21,491.0 21,775.0
Level 1    
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]    
Cash and cash equivalents 411.0 303.0
Restricted cash 42.0 34.0
Total investments 73.0 54.0
Derivatives 0.0 0.0
Unfunded revolving and delayed draw loan commitments 0.0 0.0
Level 2    
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]    
Cash and cash equivalents 0.0 0.0
Restricted cash 0.0 0.0
Total investments 661.0 360.0
Derivatives (2.0) (21.0)
Unfunded revolving and delayed draw loan commitments 0.0 0.0
Level 3    
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]    
Cash and cash equivalents 0.0 0.0
Restricted cash 0.0 0.0
Total investments 20,757.0 21,361.0
Derivatives 0.0 0.0
Unfunded revolving and delayed draw loan commitments (41.0) (57.0)
Investments measured at net asset value    
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]    
Total investments $ 5.0 $ 5.0